Search Results - "Papaxoinis, G"

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma by Strati, A., Koutsodontis, G., Papaxoinis, G., Angelidis, I., Zavridou, M., Economopoulou, P., Kotsantis, I., Avgeris, M., Mazel, M., Perisanidis, C., Sasaki, C., Alix-Panabières, C., Lianidou, E., Psyrri, A.

“…Successful application of programmed death 1 (PD1) checkpoint inhibitors in the clinic may ultimately benefit from appropriate patient selection based upon…”
Get full text

Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small‐cell carcinoma and large‐cell neuroendocrine carcinoma by Papaxoinis, G, Bille, A, McLean, E, Nonaka, D

“…Aims Large‐cell neuroendocrine carcinoma (LCNEC) and small‐cell carcinoma (SCLC) of lung encompass high‐grade neuroendocrine tumour category and share several…”
Get full text

Systemic inflammatory response index (SIRI) predicts poor survival in pancreatic cancer patients treated with FOLFIRINOX by Kamposioras, K., Razzaq, M., Ahmad, U., Damyanova, I., Papaxoinis, G.

Get full text

Financial burden and financial toxicity in patients with colorectal, gastro-oesophageal, and pancreatobiliary cancers: A UK study by Flaum, N., Papaxoinis, G., Hockenhull, K., Barriuso, J., Mansoor, W.

Get full text

Chemotherapy for recurrent cervical cancer by Pectasides, D, Kamposioras, K, Papaxoinis, G, Pectasides, E

“…Summary Purpose Cervical cancer is the second most common cancer of women worldwide and one of the leading cause of death in relative young women. This review…”
Get full text

Patient understanding of the aim and duration of treatment during the consent process by Kumaran, G., Razzaq, M., Velikova, G., Papaxoinis, G., Corker, S., Fox, F., Peters, R., Kamposioras, K.

Get full text

Association of sarcopenia with dose-limiting toxicties and survival in oesophageal adenocarcinoma treated with neoadjuvant chemotherapy by Weaver, J.M.J., Cipriano, C., McWilliam, A., Kordatou, Z., Abraham, M., Germetaki, T., Papaxoinis, G., Mansoor, W.

Get full text

Neoadjuvant FLOT: Real world toxicity from a specialist UK centre by Kordatou, Z., Papaxoinis, G., Waddell, T., Owen-Holt, V., Weaver, J., Hubner, R., Mansoor, W.

Get full text

Prognostic role white blood cell levels in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy by Ioannou, A., Demiri, S., Papaxoinis, G., Rapti, V., Klouva, E., Sarris, E., Baxevanos, P., Garefalakis, G., Goumas, G., Gouveris, P., Kourakos, P., Koumakis, G.

Get full text

The DNA damage response network in the treatment of head and neck squamous cell carcinoma by Psyrri, A., Gkotzamanidou, M., Papaxoinis, G., Krikoni, L., Economopoulou, P., Kotsantis, I., Anastasiou, M., Souliotis, V.L.

“…We sought to determine whether DNA damage response (DDR)-related aberrations predict therapeutic benefit in cisplatin-treated head and neck squamous cell…”
Get full text

Gastric Metastases Originating from Breast Cancer: Report of 8 Cases and Review of the Literature by Pectasides, D, Psyrri, A, Pliarchopoulou, K, Floros, T, Papaxoinis, G, Skondra, M, Papatsibas, G, Macheras, A, Athanasas, G, Arapantoni-Datioti, P, Economopoulos, T

“…Background: Breast cancer metastasis to the stomach is rare. It is very important to distinguish a breast cancer metastasis to the stomach from a primary…”
Get full text

A phase II window of opportunity study of preoperative olaparib (O) with cisplatin (C) or durvalumab (D) or olaparib alone in in patients with operable squamous cell head and neck carcinoma (HNSCC) (OPHELIA) by Psyrri, A., Economopoulou, P., Kotsantis, I., Koutsodontis, G., Cheila, M., Papaxoinis, G., Pectasides, D.G., Fountzilas, G., Krikoni, L., Souliotis, V.

Get full text

Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC) by Koutsodontis, G., Papaxoinis, G., Kotsantis, I., Economopoulou, P., Strati, A., Avgerinou, C., Spathas, N., Kirodimos, E., Tsavaris, O., Maratou, E., Hoxhallari, L., Anastasiou, M., Prevezanou, M., Lianidou, E., Psyrri, A.

Get full text

Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours by Clay, V., Papaxoinis, G., Sanderson, B., Valle, J. W., Howell, M., Lamarca, A., Krysiak, P., Bishop, P., Nonaka, D., Mansoor, W.

“…Background Pulmonary carcinoid (PC) tumours are classified as either typical (TC) or atypical (AC) according to mitotic index (MI) and presence of necrosis…”
Get full text

Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients by Pectasides, D, Pectasides, E, Papaxoinis, G, Andreadis, C, Papatsibas, G, Fountzilas, G, Pliarchopoulou, K, Macheras, A, Aravantinos, G, Economopoulos, T

“…Abstract Objective The objective of this retrospective study was to determine the clinical outcomes of patients with primary fallopian tube carcinoma (PFTC)…”
Get full text

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer by Pectasides, D, Xiros, N, Papaxoinis, G, Pectasides, E, Sykiotis, C, Koumarianou, A, Psyrri, A, Gaglia, A, Kassanos, D, Gouveris, P, Panayiotidis, J, Fountzilas, G, Economopoulos, T

“…Abstract Objectives The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent…”
Get full text

3: Germline sequencing of DIPNECH patients reveals a heterogeneous disease with novel SNVs in genes that are somatically mutated in other neuroendocrine malignancies by Hudson, A.M, Leong, H.S, Howell, M, Trotter, E, Papaxoinis, G, Miller, C, Nonaka, D, Brognard, J, Mansoor, W

Get full text

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG) by Papaxoinis, G., Fountzilas, G., Rontogianni, D., Dimopoulos, M. A., Pavlidis, N., Tsatalas, C., Pectasides, D., Xiros, N., Economopoulos, T.

“…Background: The aim was to examine characteristics and treatment results of patients with mucosa-associated lymphoid tissue (MALT) non-Hodgkin's lymphomas…”
Get full text

1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study by Papaxoinis, G, Kotoula, V, Alexopoulou, Z, Charalambous, E, Zagouri, F, Timotheadou, E, Gogas, H, Pentheroudakis, G, Koutras, A, Christodoulou, C, Bafaloukos, D, Aravantinos, G, Kalogeras, K.T, Pectasides, D, Fountzilas, G

Get full text

Adult Granulosa Cell Tumors of the Ovary: A Clinicopathological Study of 34 Patients by the Hellenic Cooperative Oncology Group (HeCOG) by PECTASIDES, D, PAPAXOINIS, G, FOUNTZILAS, G, ARAVANTINOS, G, PECTASIDES, E, MOURATIDOU, D, ECONOMOPOULOS, T, ANDREADIS, C. H

“…Background: Granulosa cell tumors (GCT) are rare malignant neoplasms of the ovaries with, usually, indolent biological behavior. Patients and Methods: The…”
Get full text